Skip to Content, Navigation, or Footer.
Thursday, March 26, 2026
The Daily Pennsylvanian

02-25-23 Penn Med Campus (Mehak Dhaliwal)

Capstan Therapeutics was acquired by AbbVie in $2.1 billion deal. Mehak Dhaliwal

Capstan Therapeutics was acquired by AbbVie in $2.1 billion deal.